Atenolol: Difference between revisions
| Line 23: | Line 23: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*CHF | |||
*bradycardia, severe | |||
*heart block | |||
*angina exacerbation if abrupt D/C | |||
*MI if abrupt D/C | |||
*ventricular arrhythmia during tx and if abrupt D/C | |||
*Raynaud phenomenon | |||
*bronchospasm | |||
*hypersensitivity rxn | |||
*lupus erythematosus | |||
===Common=== | ===Common=== | ||
Revision as of 22:24, 26 June 2015
General
- Type: Beta blocker
- Dosage Forms: PO
- Common Trade Names: Tenormin
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- CHF
- bradycardia, severe
- heart block
- angina exacerbation if abrupt D/C
- MI if abrupt D/C
- ventricular arrhythmia during tx and if abrupt D/C
- Raynaud phenomenon
- bronchospasm
- hypersensitivity rxn
- lupus erythematosus
Common
Pharmacology
- Half-life: 6-7h
- Metabolism: CYP450
- Excretion: urine 40-50%, feces 50%
- Mechanism of Action: selectively antagonizes beta-1 adrenergic receptors